EUPRAXIA PHARMACEUTICALS INC. - EPRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 16, 2026 | SCHEDULE 13D/A | — | — | 61,503,180 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | MANCHESTER MANAGEMENT COMPANY, LLC | 8.8% | 4,720,144 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | MANCHESTER MANAGEMENT PR, LLC | 8.8% | 4,720,144 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | MANCHESTER EXPLORER, L.P | 8.6% | 4,597,217 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | JAMES E. BESSER | 9.1% | 4,858,437 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | MORGAN C. FRANK | 9.2% | 4,904,523 | View |
| Nov 14, 2025 | SCHEDULE 13G | Beutel, Goodman & Co Ltd. | 8.0% | 4,058,899 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Robert Disbrow | 7.0% | 3,568,150 | View |
| Nov 13, 2025 | SCHEDULE 13G | MANCHESTER MANAGEMENT COMPANY, LLC | 10.4% | 5,562,971 | View |
| Nov 13, 2025 | SCHEDULE 13G | MANCHESTER MANAGEMENT PR, LLC | 10.4% | 5,562,971 | View |
| Nov 13, 2025 | SCHEDULE 13G | MANCHESTER EXPLORER, L.P. | 10.0% | 5,337,117 | View |
| Nov 13, 2025 | SCHEDULE 13G | JAMES E. BESSER | 10.9% | 5,839,557 | View |
| Nov 13, 2025 | SCHEDULE 13G | MORGAN C. FRANK | 10.6% | 5,644,423 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.